SWK Holdings Overview

  • Founded
  • 1996
Founded
  • Status
  • Public
  • Employees
  • 35
Employees
  • Stock Symbol
  • SWKH
Stock Symbol
  • Investments
  • 12
  • Share Price
  • $19.46
  • (As of Friday Closing)

SWK Holdings General Information

Description

SWK Holdings Corp is a healthcare capital provider. The company offers financing solutions to various life science companies, institutions, and inventors. It involves monetizing cash flow streams derived from commercial-stage products and related intellectual property through royalty purchases and financings, as well as through the creation of synthetic revenue interests in commercialized products. Through its wholly-owned subsidiary, it also provides non-discretionary investment advisory services to institutional clients. The company's operating segments are Finance Receivables and Pharmaceutical Development Services. It generates maximum revenue from the Finance Receivables segment.

Contact Information

Website
www.swkhold.com
Ownership Status
Publicly Held
Financing Status
Corporate Backed or Acquired
Primary Industry
Private Equity
Other Industries
Specialized Finance
Stock Exchange
NAS
Primary Office
  • 14755 Preston Road
  • Suite 105
  • Dallas, TX 75254
  • United States
+1 (972) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

SWK Holdings Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$19.46 $19.26 $12.58 - $20.49 $249M 12.8M 22.1K $2.06

SWK Holdings Financials Summary

In Thousands,
USD
TTM 30-Jun-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018
EV 231,980 173,591 150,534 104,939
Revenue 53,175 36,712 30,747 25,990
EBITDA 41,553 16,220 22,134 6,425
Net Income 26,345 5,202 23,828 6,195
Total Assets 272,823 273,901 254,372 215,662
Total Debt 0 11,758 0 13
Public Fundamental Data provided by Morningstar, Inc. disclaimer

SWK Holdings Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore SWK Holdings‘s full profile, request access.

Request a free trial

SWK Holdings Executive Team (20)

Name Title Board Seat Contact Info
Winston Black Chairman and Chief Executive Officer
Yvette Heinrichson Controller
Brannon Morisoli JD Senior Analyst
Michael Miner Senior Analyst
Jody Staggs Vice President
You’re viewing 5 of 20 executive team members. Get the full list »

SWK Holdings Board Members (14)

Name Representing Role Since
00000 00000000 00.0 Self Board Member 000 0000
00000000000 0000 Self Board Member 000 0000
0000 00000 SWK Holdings Board Member 000 0000
0. 00000 00000 SWK Holdings Board Member 000 0000
000000 00000 SWK Holdings Board Member 000 0000
You’re viewing 5 of 14 board members. Get the full list »

SWK Holdings Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

SWK Holdings Investments (12)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000 0000000000 00 08-Jul-2021 00 000000000000000 00.00 Personal Products 0000000 00000
0000 0000000000 00 28-Oct-2020 00 000000000000000 Personal Products 0000000 00000
0000000 000000000 26-Aug-2019 0000000000 000.00 Drug Discovery 0000000 00000
0000 000 000000000 13-Jun-2018 0000000000: 000000 000 Other Devices and Supplies
Opiant Pharmaceuticals (NARCAN Nasal Spray Royalties) 15-Dec-2016 Buyout/LBO 000.00 Buildings and Property 0000000 00000
You’re viewing 5 of 12 investments. Get the full list »

SWK Holdings Exits (3)

Company Name Exit Date Exit Type Exit Size Status Buyers
0000 000 000000000 13-Jun-2018 0000000000: 000000 000 Completed
  • 000 00000000
000000000 0000000 17-Dec-2013 00000 00000 00 0000 Completed
  • 2 buyers
Holmdel Pharmaceuticals (InnoPran XL) 20-Dec-2012 Corporate Asset Purchase 0000 Completed
  • 2 buyers
To view SWK Holdings’s complete exits history, request access »